FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

18 Web Sites Warned About Illegal Botox Sales

[ Price : $8.95]

FDA warns 18 Internet companies that they are illegally selling Botox products.

OAC Survey Calls for FDA Action on Obesity Drug Testing, Labeling

[ Price : $8.95]

An Obesity Action Coalition survey finds that people want FDA and drug companies to change the way that obesity drugs are tested a...

FDA Approves Caplyta for Major Depressive Disorder

[ Price : $8.95]

FDA approves an expanded use for Johnson & Johnsons Caplyta (lumateperone) as an adjunctive therapy with oral antidepressants in a...

Stop Desiccated Thyroid Enforcement: Congressman

[ Price : $8.95]

Rep. Abe Hamadeh calls on FDA to suspend any enforcement actions against desiccated thyroid medications due to the possibility tha...

Makary Reassures Stakeholders that FDA Remains Robust

[ Price : $8.95]

Addressing a Milken Institute annual summit, FDA commissioner Marty Makary reassures stakeholders that despite recent departures a...

FDA Warns Apotex Canadian Manufacturing Site

[ Price : $8.95]

FDA issues a Warning Letter to Apotex, citing significant GMP violations at the companys Richmond Hill, Ontario, facility, includi...

White House Supporting Makary in Turmoil: Report

[ Price : $8.95]

Politico reports that President Trump and HHS are standing by FDA commissioner Marty Makary as the agency weathers the sudden depa...

Centessa Promising Data for Sleep Disorder Drug

[ Price : $8.95]

Centessa Pharmaceuticals reports encouraging clinical data for its oral OX2R agonist ORX750 in patients with narcolepsy Types 1 an...

Liebel-Flarsheim CGMP Violations Cited

[ Price : $8.95]

FDA warns Liebel-Flarsheim in Raleigh, NC, about CGMP violations in its production of finished drugs.

Alembic Pharmaceuticals FDA-483 Out

[ Price : $8.95]

FDA releases the form FDA-483 with four observations from an inspection at the Alembic Pharmaceuticals active pharmaceutical ingre...